These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12200645)

  • 21. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation.
    Riminucci M; Fisher LW; Shenker A; Spiegel AM; Bianco P; Gehron Robey P
    Am J Pathol; 1997 Dec; 151(6):1587-600. PubMed ID: 9403710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.
    Kochar IP; Kulkarni KP
    Indian Pediatr; 2010 Jul; 47(7):633-5. PubMed ID: 20683120
    [No Abstract]   [Full Text] [Related]  

  • 24. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy.
    Rauch F; Travers R; Glorieux FH
    J Clin Endocrinol Metab; 2006 Feb; 91(2):511-6. PubMed ID: 16291701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
    McClung MR; Wasnich RD; Recker R; Cauley JA; Chesnut CH; Ensrud KE; Burdeska A; Mills T;
    J Bone Miner Res; 2004 Jan; 19(1):11-8. PubMed ID: 14753731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
    Rosen HN; Moses AC; Garber J; Ross DS; Lee SL; Greenspan SL
    Calcif Tissue Int; 1998 Nov; 63(5):363-8. PubMed ID: 9799818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.
    Bauss F; Schenk RK; Hört S; Müller-Beckmann B; Sponer G
    J Pharmacol Toxicol Methods; 2004; 50(1):25-34. PubMed ID: 15233964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.
    Glorieux FH; Bishop NJ; Plotkin H; Chabot G; Lanoue G; Travers R
    N Engl J Med; 1998 Oct; 339(14):947-52. PubMed ID: 9753709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis.
    Bertin H; Moussa MS; Komarova S
    Rev Endocr Metab Disord; 2023 Dec; 24(6):1103-1119. PubMed ID: 37632645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone.
    Chapurlat RD; Delmas PD; Liens D; Meunier PJ
    J Bone Miner Res; 1997 Oct; 12(10):1746-52. PubMed ID: 9333137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
    Bhadada SK; Bhansali A; Das S; Singh R; Sen R; Agarwal A; Mittal BR; Nahar U; Dutta P; Khandelwal N
    Indian J Med Res; 2011 May; 133(5):504-9. PubMed ID: 21623035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrous dysplasia of bone.
    Chapurlat RD; Meunier PJ
    Baillieres Best Pract Res Clin Rheumatol; 2000 Jun; 14(2):385-98. PubMed ID: 10925751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases.
    Chan B; Zacharin M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2017-20. PubMed ID: 16551739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of therapy with and withdrawal from denosumab in fibrous dysplasia and McCune-Albright syndrome: an observational study.
    Meier ME; Clerkx SN; Winter EM; Pereira AM; van de Ven AC; van de Sande MAJ; Appelman-Dijkstra NM
    J Bone Miner Res; 2021 Sep; 36(9):1729-1738. PubMed ID: 34076303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.
    Meier ME; Hagelstein-Rotman M; Streefland TCM; Winter EM; Bravenboer N; Appelman-Dijkstra NM
    Bone; 2023 Jun; 171():116744. PubMed ID: 36958543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.
    Wilkinson JM; Jackson B; Eastell R
    Calcif Tissue Int; 2003 Oct; 73(4):326-31. PubMed ID: 12874697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O; Yoshikata I; Kikuchi R; Nakayama M; Uchiyama Y; Hirahara F; Gorai I
    J Bone Miner Res; 2000 Aug; 15(8):1537-44. PubMed ID: 10934652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrous dysplasia: differential diagnosis from Paget's disease].
    Wagner P; Heilmann P; Schulz A; Nawroth P; Kasperk Ch
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2264-8. PubMed ID: 12397541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.
    Smith MR; McGovern FJ; Zietman AL; Fallon MA; Hayden DL; Schoenfeld DA; Kantoff PW; Finkelstein JS
    N Engl J Med; 2001 Sep; 345(13):948-55. PubMed ID: 11575286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.